175 related articles for article (PubMed ID: 36770334)
1. Melanoma Cell Reprogramming and Awakening of Antitumor Immunity as a Fingerprint of Hyper-Harmonized Hydroxylated Fullerene Water Complex (3HFWC) and Hyperpolarized Light Application
Markelić M; Mojić M; Bovan D; Jelača S; Jović Z; Purić M; Koruga D; Mijatović S; Maksimović-Ivanić D
Nanomaterials (Basel); 2023 Jan; 13(3):. PubMed ID: 36770334
[TBL] [Abstract][Full Text] [Related]
2. Combined Action of Hyper-Harmonized Hydroxylated Fullerene Water Complex and Hyperpolarized Light Leads to Melanoma Cell Reprogramming In Vitro.
Markelić M; Drača D; Krajnović T; Jović Z; Vuksanović M; Koruga D; Mijatović S; Maksimović-Ivanić D
Nanomaterials (Basel); 2022 Apr; 12(8):. PubMed ID: 35458039
[TBL] [Abstract][Full Text] [Related]
3. Comparative Studies of the Structural and Physicochemical Properties of the First Fullerene Derivative FD-C
Koruga D; Stanković I; Matija L; Kuhn D; Christ B; Dembski S; Jevtić N; Janać J; Pavlović V; De Wever B
Nanomaterials (Basel); 2024 Mar; 14(5):. PubMed ID: 38470808
[TBL] [Abstract][Full Text] [Related]
4. Influence of hyper-harmonized fullerene water complex on collagen quality and skin function.
Miljkovic S; Jeftic B; Sarac D; Matovic V; Slavkovic M; Koruga D
J Cosmet Dermatol; 2020 Feb; 19(2):494-501. PubMed ID: 31141275
[TBL] [Abstract][Full Text] [Related]
5. Mechanisms of skin moisturization with hyperharmonized hydroxyl modified fullerene substance.
Miljkovic S; Jeftic B; Stankovic I; Stojiljkovic N; Koruga D
J Cosmet Dermatol; 2021 Sep; 20(9):3018-3025. PubMed ID: 33533143
[TBL] [Abstract][Full Text] [Related]
6. Physiological Response, Oxidative Stress Assessment and Aquaporin Genes Expression of Cherry Tomato (
Subotić A; Jevremović S; Milošević S; Trifunović-Momčilov M; Đurić M; Koruga Đ
Plants (Basel); 2022 Oct; 11(21):. PubMed ID: 36365262
[TBL] [Abstract][Full Text] [Related]
7. The Second Derivative of Fullerene C
Matija LR; Stankovic IM; Puric M; Miličić M; Maksimović-Ivanić D; Mijatovic S; Krajnović T; Gordic V; Koruga DL
Micromachines (Basel); 2023 Nov; 14(12):. PubMed ID: 38138321
[TBL] [Abstract][Full Text] [Related]
8. Targeting the vascular endothelial growth factor receptor-1 by the monoclonal antibody D16F7 to increase the activity of immune checkpoint inhibitors against cutaneous melanoma.
Lacal PM; Atzori MG; Ruffini F; Scimeca M; Bonanno E; Cicconi R; Mattei M; Bernardini R; D'Atri S; Tentori L; Graziani G
Pharmacol Res; 2020 Sep; 159():104957. PubMed ID: 32485280
[TBL] [Abstract][Full Text] [Related]
9. Blockades of effector T cell senescence and exhaustion synergistically enhance antitumor immunity and immunotherapy.
Liu X; Si F; Bagley D; Ma F; Zhang Y; Tao Y; Shaw E; Peng G
J Immunother Cancer; 2022 Oct; 10(10):. PubMed ID: 36192086
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages.
Di Martile M; Farini V; Consonni FM; Trisciuoglio D; Desideri M; Valentini E; D'Aguanno S; Tupone MG; Buglioni S; Ercolani C; Gallo E; Amadio B; Terrenato I; Foddai ML; Sica A; Del Bufalo D
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32269145
[TBL] [Abstract][Full Text] [Related]
11. Anticancer effects of fullerene [C60] included in polyethylene glycol combined with visible light irradiation through ROS generation and DNA fragmentation on fibrosarcoma cells with scarce cytotoxicity to normal fibroblasts.
Liao F; Saitoh Y; Miwa N
Oncol Res; 2011; 19(5):203-16. PubMed ID: 21542456
[TBL] [Abstract][Full Text] [Related]
12. Hydroxylated fullerene: a potential antiinflammatory and antioxidant agent for preventing mouse preterm birth.
Wakimoto T; Uchida K; Mimura K; Kanagawa T; Mehandjiev TR; Aoshima H; Kokubo K; Mitsuda N; Yoshioka Y; Tsutsumi Y; Kimura T; Yanagihara I
Am J Obstet Gynecol; 2015 Nov; 213(5):708.e1-9. PubMed ID: 26196453
[TBL] [Abstract][Full Text] [Related]
13. Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis.
Hu S; Ma J; Su C; Chen Y; Shu Y; Qi Z; Zhang B; Shi G; Zhang Y; Zhang Y; Huang A; Kuang Y; Cheng P
Acta Biomater; 2021 Nov; 135():567-581. PubMed ID: 34506976
[TBL] [Abstract][Full Text] [Related]
14. [New strategy of cancer immunotherapy: irradiation or chemotherapeutics-induced lymphopenia combined with immune reconstitution and tumor vaccine].
Ma J; Wang YL; Hu HM; Fox BA; Si LS
Zhonghua Zhong Liu Za Zhi; 2005 Aug; 27(8):452-6. PubMed ID: 16188138
[TBL] [Abstract][Full Text] [Related]
15. Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth.
Cao M; Yan H; Han X; Weng L; Wei Q; Sun X; Lu W; Wei Q; Ye J; Cai X; Hu C; Yin X; Cao P
J Immunother Cancer; 2019 Nov; 7(1):326. PubMed ID: 31775862
[TBL] [Abstract][Full Text] [Related]
16. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
Front Immunol; 2018; 9():1132. PubMed ID: 29875777
[TBL] [Abstract][Full Text] [Related]
17. Secretome from senescent melanoma engages the STAT3 pathway to favor reprogramming of naive melanoma towards a tumor-initiating cell phenotype.
Ohanna M; Cheli Y; Bonet C; Bonazzi VF; Allegra M; Giuliano S; Bille K; Bahadoran P; Giacchero D; Lacour JP; Boyle GM; Hayward NF; Bertolotto C; Ballotti R
Oncotarget; 2013 Dec; 4(12):2212-24. PubMed ID: 24344100
[TBL] [Abstract][Full Text] [Related]
18. Combined therapies that induce senescence and stabilize p53 block melanoma growth and prompt antitumor immune responses.
Vilgelm A; Richmond A
Oncoimmunology; 2015 Aug; 4(8):e1009299. PubMed ID: 26405565
[TBL] [Abstract][Full Text] [Related]
19. C
Grebinyk A; Grebinyk S; Prylutska S; Ritter U; Matyshevska O; Dandekar T; Frohme M
Free Radic Biol Med; 2018 Aug; 124():319-327. PubMed ID: 29940354
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel Reduces Tumor Growth by Reprogramming Tumor-Associated Macrophages to an M1 Profile in a TLR4-Dependent Manner.
Wanderley CW; Colón DF; Luiz JPM; Oliveira FF; Viacava PR; Leite CA; Pereira JA; Silva CM; Silva CR; Silva RL; Speck-Hernandez CA; Mota JM; Alves-Filho JC; Lima-Junior RC; Cunha TM; Cunha FQ
Cancer Res; 2018 Oct; 78(20):5891-5900. PubMed ID: 30104241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
